We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Feil Family Brain & Mind Research Institute

You are here

The Role of the Adipocyte Hormone Leptin in Alzheimer's Disease.

TitleThe Role of the Adipocyte Hormone Leptin in Alzheimer's Disease.
Publication TypeJournal Article
Year of Publication2016
AuthorsIshii M
JournalKeio J Med
Volume65
Issue1
Pagination21
Date Published2016
ISSN1880-1293
Abstract

Cognitive deficits are the major manifestation of Alzheimer's disease (AD); however, weight loss can precede the mental decline and correlates with disease severity. Thus, brain circuits controlling body weight may be altered early in AD and could be intrinsic to AD pathobiology. In mouse models, we found that amyloid-beta, a major pathogenic factor in AD, could inhibit hypothalamic neurons in the leptin pathway, which was associated with early body weight/metabolic deficits. Ongoing research seeks to elucidate the mechanisms underlying the body weight/metabolic deficits and hypothalamic dysfunction in AD using both mouse models and clinically relevant human studies.(Presented at the 1919th Meeting, March 2, 2016).

DOI10.2302/kjm.65-002-ABST
Alternate JournalKeio J Med
PubMed ID27040887